20/20 BIOLABS, INC. Accounts Payable
20/20 BIOLABS, INC. (AIDX) had Accounts Payable of $1.03 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $1.03M.
- 2026-03-31: Accounts Payable, Current $980.49K.
- 2025-12-31: Accounts Payable, Current $868.54K.
- 2024-12-31: Accounts Payable, Current $372.30K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $1.03M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $980.49K 10-Q · filed 2026-05-20 |
| 2025-12-31 | $868.54K 10-Q · filed 2026-08-14 |
| 2024-12-31 | $372.30K POS AM · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |